Ready to invest?
Open a free brokerage account and start building your portfolio today.
Open a free brokerage account and start building your portfolio today.
CDXI
$0.00
Connect your bank account to understand your spending habits and explore hypothetical growth scenarios. For educational purposes only — not investment advice.
Cardax is a biopharmaceutical company engaged in the development and commercialization of dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. Cardax's product platform consists of a commercially available dietary supplement, ZanthoSyn®, and pharmaceutical candidates, CDX-101 and CDX-301, which are in pre-clinical development for cardiovascular and macular disorders. The safety and efficacy of the Company's products hav...
View full profileEducational illustration: hypothetical DCA into Cardax Inc (CDXI) over the past year. This is not a recommendation to buy this security.
Total Invested
$1,400
14 months
Worth Today
$310
at current price
Loss
-$1,090
-77.9% return
Hypothetical illustration using historical prices. This is for educational purposes only and is not investment advice. Past performance does not guarantee future results. Nuvestan is not a registered investment adviser. Consult a financial professional before making investment decisions.